Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8486072 | Vaccine | 2018 | 7 Pages |
Abstract
The majority of the participants lacked antibodies against at least one of the measles/mumps/rubella (58%) and diphtheria/tetanus/pertussis (72%) vaccine components and against hepatitis B virus (82%) and might thus profit from vaccination. Oral fluid is a suitable alternative and non-invasive specimen for measles/rubella antibody prevalence studies.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Judith M. Hübschen, Emilie Charpentier, Pierre Weicherding, Claude P. Muller,